Abstract
The blockade of the PD-1 pathway can increase the production of interferon? by tumor-specific T cells located within or in the proximity of the malignant lesion, thereby increasing the chemokine-dependent trafficking of immune effector cells. This can boost the efficacy of adoptive T-cell therapy to achieve superior antitumor responses.
Original language | English (US) |
---|---|
Article number | e22691 |
Journal | OncoImmunology |
Volume | 2 |
Issue number | 2 |
DOIs |
|
State | Published - Feb 2013 |
Keywords
- Adoptive cell therapy
- Cancer immunotherapy
- Checkpoint blockade
- Melanoma
- PD-1
- PD-L1
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology